Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BridgeBio Oncology Therapeutics, Inc. | 1,114,400 | reported | 01 Jan 2026 | tx 4+3,228,531−1,114,400 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Jan 2026 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 1,114,400 | 0.00 USD | deriv |
| 10 Dec 2025 | OTHER | BridgeBio Oncology Therapeutics, Inc. | 1,114,400 | — | deriv |
| 02 Oct 2025 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 1,614,400 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | BridgeBio Oncology Therapeutics, Inc. | 499,731 | 0.00 USD | deriv |